Literature DB >> 1616365

Increased levels of serum IgA as IgA1 monomers in ankylosing spondylitis.

H Hocini1, S Iscaki, C Benlahrache, L Vitalis, X Chevalier, B Larget-Piet, J P Bouvet.   

Abstract

The various subsets of serum IgA were determined in 43 patients with ankylosing spondylitis to investigate the putative mucosal origin of increased IgA concentrations in this disease. Total IgA was shown to be increased and weakly correlated with the erythrocyte sedimentation rate (ESR). In contrast, although the mean concentration (but not the median) of secretory IgA (SIgA) was slightly increased, no correlation was found with total IgA nor the ESR. Moreover, molecular sieving of nine serum samples selected for their high concentrations of total IgA, and absorption with insoluble jacalin showed these immunoglobulins to be essentially monomers of the IgA1 subclass. These results are consistent with a non-secretory origin of the increase of serum IgA, which must be ascribed to the central immune system.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1616365      PMCID: PMC1004748          DOI: 10.1136/ard.51.6.790

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  24 in total

1.  [The immunoglobulins in ankylosing spondylitis].

Authors:  W Kriegel; R Burger; W Kapp; J Alexopulos
Journal:  Verh Dtsch Ges Rheumatol       Date:  1969

2.  Human secretory component-I. Evidence for a new antigenic specificity.

Authors:  S Iscaki; C Geneste; J Pillot
Journal:  Immunochemistry       Date:  1978-06

3.  Human secretory component. II. Easy detection of abnormal amounts of combined secretory component in human sera.

Authors:  S Iscaki; C Geneste; S d'Azambuja; J Pillot
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

4.  Urinary IgA in IgA nephropathy and Henoch-Schoenlein purpura.

Authors:  J H Galla; M F Spotswood; L A Harrison; J Mestecky
Journal:  J Clin Immunol       Date:  1985-09       Impact factor: 8.317

5.  Association of inflammation with raised serum IgA in ankylosing spondylitis.

Authors:  P Cowling; R Ebringer; A Ebringer
Journal:  Ann Rheum Dis       Date:  1980-12       Impact factor: 19.103

6.  Estimation of polymeric IgA in human serum: an assay based on binding of radiolabeled human secretory component with applications in the study of IgA nephropathy, IgA monoclonal gammopathy, and liver disease.

Authors:  M M Newkirk; M H Klein; A Katz; M M Fisher; B J Underdown
Journal:  J Immunol       Date:  1983-03       Impact factor: 5.422

7.  Correlation of immunoglobulin and C reactive protein levels in ankylosing spondylitis and rheumatoid arthritis.

Authors:  K M Sanders; A Hertzman; M R Escobar; B H Littman
Journal:  Ann Rheum Dis       Date:  1987-04       Impact factor: 19.103

8.  An enzyme-linked immunosorbent assay for differential quantitation of secretory immunoglobulins of the A and M isotypes in human serum.

Authors:  D Kvale; P Brandtzaeg
Journal:  J Immunol Methods       Date:  1986-01-22       Impact factor: 2.303

9.  Acute-phase proteins and serum immunoglobulins in ankylosing spondylitis.

Authors:  M R Laurent; G S Panayi
Journal:  Ann Rheum Dis       Date:  1983-10       Impact factor: 19.103

10.  Reassessment of levels of secretory IgA in pathological sera using a quantitative radioimmunoassay.

Authors:  D Delacroix; J P Vaerman
Journal:  Clin Exp Immunol       Date:  1981-03       Impact factor: 4.330

View more
  8 in total

1.  Serum secretory immunoglobulins in ankylosing spondylitis.

Authors:  D Wendling; J M Didier; E Seilles
Journal:  Clin Rheumatol       Date:  1996-11       Impact factor: 2.980

2.  Henoch-Schonlein purpura associated with HLA-B27 positive axial spondyloarthritis in a young man.

Authors:  Kevin John John; Mohammad Sadiq; Meera Thomas; Vijay Prakash Turaka
Journal:  BMJ Case Rep       Date:  2019-05-24

Review 3.  Ankylosing spondylitis, IgA, and transforming growth factors.

Authors:  J R Archer
Journal:  Ann Rheum Dis       Date:  1995-07       Impact factor: 19.103

4.  Unexpectedly high levels of some presumably protective secretory immunoglobulin A antibodies to dental plaque bacteria in salivas of both caries-resistant and caries-susceptible subjects.

Authors:  H Hocini; S Iscaki; J P Bouvet; J Pillot
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

5.  Increased IgA antibodies to cytokeratins in the spondyloarthropathies.

Authors:  A A Borg; N B Nixon; P T Dawes; D L Mattey
Journal:  Ann Rheum Dis       Date:  1994-06       Impact factor: 19.103

6.  IgA1 and IgA2 subclass antibodies against Klebsiella pneumoniae in the sera of patients with peripheral and axial types of ankylosing spondylitis.

Authors:  O Mäki-Ikola; M Nissilä; K Lehtinen; M Leirisalo-Repo; K Granfors
Journal:  Ann Rheum Dis       Date:  1995-08       Impact factor: 19.103

7.  Spectrums and Prognosis of Kidney Disease in Patients with Ankylosing Spondylitis.

Authors:  Dafeng He; Rong Wang; Shaoshan Liang; Dandan Liang; Feng Xu; Caihong Zeng; Zheng Tang
Journal:  Kidney Dis (Basel)       Date:  2020-08-26

Review 8.  B Cell Involvement in the Pathogenesis of Ankylosing Spondylitis.

Authors:  Rick Wilbrink; Anneke Spoorenberg; Gwenny M P J Verstappen; Frans G M Kroese
Journal:  Int J Mol Sci       Date:  2021-12-11       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.